Integra LifeSciences IART EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Integra LifeSciences’s reported figures.
The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Integra LifeSciences's EBITDA?
- Integra LifeSciences (IART) reported EBITDA of $53.68M in Q1 2026.
- How has Integra LifeSciences's EBITDA changed year-over-year?
- Integra LifeSciences's EBITDA increased by 111.4% year-over-year, from $25.4M to $53.68M.
- What is the long-term trend for Integra LifeSciences's EBITDA?
- Over 4 years (2021 to 2025), Integra LifeSciences's EBITDA has grown at a 1.2% compound annual growth rate (CAGR), from $333.98M to -$349.62M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.